Cetuximab fails India’s cost-effectiveness test unless biosimilar price halves
A model-based economic evaluation from PGIMER Chandigarh finds that adding cetuximab to radiotherapy or platinum-based chemotherapy for head and neck ...
Tag: Ayushman Bharat PM-JAY
POPULAR NEWS
-
BALF Metagenomic Sequencing Maps Lower-Airway Microbial Shifts in Tuberculosis
-
Cetuximab fails India’s cost-effectiveness test unless biosimilar price halves
-
Uncertainty-aware Bayesian neural network brings confidence scores to breast cancer AI
-
SV40LT mouse fibroblast line retains feeder function without detected tumors